• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Outcomes after left ventricular assist device implantation significantly worse for those with end-stage renal disease

byJames EnglandandAnees Daud
January 3, 2018
in Cardiology, Chronic Disease, Emergency, Imaging and Intervention, Nephrology, Surgery, Urology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Patients with end-stage renal disease (ESRD) have significantly worse survival outcomes following left ventricular assist device (LVAD) implantation compared to recipients without ESRD.

2. The median time to death was substantially shorter in those with ESRD, with many patients dying during the index hospitalization.

Evidence Rating Level: 2 (Good)

Study Rundown: With advancement of technology and growing evidence for improved survival and quality of life, LVAD utilization is increasing both as bridge to transplantation and destination therapy in those not eligible for transplant. Patients with ESRD are not usually considered for transplant and many have comorbid heart failure. The outcomes of LVAD therapy in patients with ESRD is not known but knowledge of the typical clinical course may be important for discussion of risks and benefits of LVAD as destination therapy. The current study used Medicare data to evaluate the outcomes of patients with ESRD who received LVAD compared to those without ESRD. The study found that overall survival is substantially worse amongst LVAD recipients with ESRD. More than half of patients with ESRD died during the index hospitalization. The median time to death was significantly shorter for patients with ESRD.

The study currently highlights the challenges in using LVAD therapy in patients with ESRD. The strength of this study includes its cohort from a national database, and focus on patients with ESRD rather than just transient dialysis at time of device insertion. The main limitations of the study include the administrative level data collection, lack of information on LVAD indication, and other important data regarding clinical context.

Click to read the study, published in JAMA Internal Medicine

Relevant Reading: Proteinuria in patients receiving left ventricular assist devices is highly associated with renal failure and mortality

RELATED REPORTS

Interatrial shunt device not effective in patients with symptomatic heart failure

Risk of chronic kidney disease progression may be greater amongst patients with obstructive sleep apnea

Wellness Check: Sleep

In-Depth [retrospective cohort]: This study used data from the United States Renal Data System (USRDS) to identify patients who were on chronic dialysis or having received a renal transplant prior to time of LVAD insertion. Patients were included from 2003 to 2013, and compared to a 5% Medicare representative sample of those without ESRD who underwent LVAD therapy. Patients were excluded if they did not have Medicare coverage for the year before LVAD placement, or in whom LVAD preceded renal failure. The primary outcome was death after LVAD placement.

The study found that of the 155 Medicare beneficiaries with ESRD who received LVAD, 127 patients (81.9%) died during follow up compared to 36.4% of the comparison cohort. During the index hospitalization for LVAD placement, 51.4% of ESRD patients died compared to 4% of non-ESRD recipients. The median time to death was 16 days (IQR 2-447 days) for ESRD patients compared to 2125 days (IQR, 565-3850 days). In multivariate analysis the risk of death after adjustment for covariates was substantially higher in the ESRD cohort (hazard ratio, 36.3; 95%CI, 15.6-84.5).

Image: CC/Wiki

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chronic kidney diseasecongestive heart failurerenal failure
Previous Post

Herpes simplex virus infection uncommon in infants undergoing meningitis evaluation

Next Post

Regional variation in CT imaging is associated with nephrectomy risk

RelatedReports

30-Day mortality decreased in UK pediatric cardiac surgery from 2000-2010
Cardiology

Interatrial shunt device not effective in patients with symptomatic heart failure

March 29, 2022
CPAP may not decrease cardiovascular events in sleep apnea
Nephrology

Risk of chronic kidney disease progression may be greater amongst patients with obstructive sleep apnea

March 14, 2022
Decline in adolescent sleep duration over past 20 years
Wellness

Wellness Check: Sleep

March 10, 2022
Long-term outcomes for off-pump and on-pump CABG are similar
Cardiology

Predicted long-term effects of dapagliflozin in heart failure suggest association with improved event-free survival

November 8, 2021
Next Post
Attenuation values may help differentiate renal neoplasm from simple cyst on contrast-enhanced CT

Regional variation in CT imaging is associated with nephrectomy risk

2 Minute Medicine Physician Press Podcast January 2018

Rapid time to revascularization after ischemic stroke associated with improved functional outcomes

Systemic atherosclerosis linked with intracranial atherosclerotic disease-related stroke and worse prognosis

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Pelvic lymph node radiotherapy and androgen deprivation therapy augment progression-free status following prostatectomy
  • Operating the day after performing surgery the previous night not associated with adverse patient outcomes
  • Gratitude-focused writing may improve mental wellness during periods of chronic stress
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.